Long-term outcome of epileptic dogs treated with implantable vagus nerve stimulators
Journal of Veterinary Internal Medicine · 2023
DOI: 10.1111/jvim.16908 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Veterinary Internal Medicine, 2023. Verfasst von Thomas R Harcourt-Brown und 1 weiteren Autor:innen. Beteiligte Einrichtung: Langford Vets, University of Bristol School of Veterinary Sciences, Bristol, UK. Hauptthemen laut MEDLINE: Epilepsy, Vagus Nerve Stimulation, Dog Diseases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
The long-term effect of implantable vagus nerve stimulators (VNS) on seizures has not been evaluated in epileptic dogs.
Objectives
Report seizure frequency in medication-resistant epileptic dogs before and after VNS implantation. Animals Twelve client-owned dogs with idiopathic epilepsy and >1 seizure day per 3 weeks despite 3 months of appropriate use of 2 antiseizure medications and seizure diaries maintained 6 months before and >12 months after VNS implantation.
Methods
Uncontrolled, open-label, before and after study. Mean monthly seizures and inter-seizure periods obtained from contemporaneous seizure diaries in the 6 months before implantation were compared with 0 to 6 months, 7 to 12 months, and subsequent 12-month periods after implantation. The number of dogs with >50% decrease in seizure frequency, >3 times increase in inter-ictal period interval, and seizure freedom for >3 months at the time of death or last follow-up were recorded.
Results
Five of 12 dogs were euthanized <12 months after implantation. All 7 remaining dogs showed >50% decrease in seizure frequency until last follow-up, starting at a median of 37 to 48 months after implantation (range, 0-6 to 61-72 months) and a >3-fold increase in mean inter-seizure interval starting a median of 25 to 36 months after implantation (range, 0-6 months to 49-60 months), 3/7 dogs were seizure-free at death or last follow-up. Conclusions and Clinical Importance Monthly seizure frequencies decreased and inter-seizure intervals increased in all dogs 2 to 3 years after VNS implantation, but a high proportion were euthanized before this time point. Prospective clinical trials are required to establish causality and the magnitude of this association.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Langford Vets, University of Bristol School of Veterinary Sciences, Bristol, UK.
- Bristol Royal Hospital for Children, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK.
ORCID-Profile: Thomas R Harcourt-Brown
Zitieren
APA
Harcourt-Brown, T. R., & Carter, M. (2023). Long-term outcome of epileptic dogs treated with implantable vagus nerve stimulators. Journal of Veterinary Internal Medicine. https://doi.org/10.1111/jvim.16908
Vancouver
Harcourt-Brown TR, Carter M. Long-term outcome of epileptic dogs treated with implantable vagus nerve stimulators. Journal of Veterinary Internal Medicine. 2023. doi:10.1111/jvim.16908
BibTeX
@article{HarcourtBrown2023,
author = {Harcourt-Brown, Thomas R and Carter, Michael},
title = {Long-term outcome of epileptic dogs treated with implantable vagus nerve stimulators},
journal = {Journal of Veterinary Internal Medicine},
year = {2023},
doi = {10.1111/jvim.16908}
}
EUVIMED